Bloomberg Billionaires Index

View profiles for each of the world’s 500 richest people, see the biggest movers, and compare fortunes or track returns.

#156 Patrick Soon-Shiong $9.17B

Random fact: Performed first pig-to-man cell transplant for diabetic patients.


Soon-Shiong became a billionaire selling two drug companies: APP Pharmaceuticals and Abraxis BioScience. He sold APP to Fresenius Medical Care for $4.6 billion in 2008, and Abraxis to Celgene for $2.8 billion in 2010. The billionaire owns a 4.5 percent stake in the Los Angeles Lakers professional basketball team.

As of July 26, 2017:
Last change +$31.9M (+0.3%)
YTD change +$340M (+3.9%)
Industry Health Care
Biggest asset Cash
Citizenship United States
Age 64
Wealth Self-made
View net worth over:   Max 1 year 1 quarter 1 month 1 week

Relative Value

Patrick Soon-Shiong's net worth of $9.17B can buy ...

troy ounces of gold
barrels of crude oil

... and is equivalent to ...

of the GDP of the United States
of the total wealth of the 500 richest people in the world
of the top 100 U.S. college endowments
of the top 200 U.S. executives’ total awarded compensation
of U.S. existing home sales
times the median U.S. household income

Latest News

Net Worth Summary

Private asset
Public asset
Misc. liabilities
Confidence rating:

The majority of Soon-Shiong's fortune is derived from the proceeds he accumulated selling two pharmaceutical companies. He sold publicly traded APP Pharmaceuticals for $4.6 billion in cash to German drug manufacturer Fresenius in 2008. The billionaire, who served as APP's chairman and CEO, owned more than 80 percent of the stock. As part of a contingent value rights agreement, he received an extra $6 per share, bringing his total proceeds from the sale to about $3.8 billion.

Soon-Shiong sold Abraxis BioScience for $2.9 billion in cash and stock to biotechnology company Celgene in 2010. He received about $2 billion in cash and a 2 percent stake in Celgene for his 33 million shares of Abraxis. Soon-Shiong said he hadn't sold his stake in an October 2016 interview.

The billionaire has invested $1 billion in Nantworks, a closely held information technology development company, which attempts to apply technology to the treatment of cancer. Through Nantworks he owns about 60 percent of publicly traded NantHealth, according to a June SEC filing. Before the company's June 2016 initial public offering he was calculated to own a 90 percent stake.

Soon-Shiong owns more than 7 million shares in Allscripts through closely held NantCapital, according to a June 2015 NantHealth press release. Through Cambridge Equities and a family foundation, Soon-Shiong controls 57 percent of publicly traded NantKwest including options, according to a December 2016 filing.

Through California Capital Z, Global Grid and other investment companies, Soon-Shiong owns other assets, including stakes in publicly traded Jakks Pacific and tronc. He also owns a 4.5 percent interest in the Los Angeles Lakers professional basketball team, a stake he bought from retired Lakers star Earvin "Magic" Johnson for $27 million in October 2010. The team is valued at about $2.5 billion, according to Marc Ganis, president of Chicago-based consultancy firm Sportscorp Ltd.

Soon-Shiong confirmed his public holdings.


Birthdate: 7/29/1952
Family: Married, 2 children
Education: Science, University of British Columbia/The, Master's Degree Medicine, University of The Witwatersrand, Graduated MD

Soon-Shiong was born in 1952 in Port Elizabeth, South Africa, to Chinese immigrant parents. His father had worked as a village doctor before fleeing China with his wife during World War II. After receiving his medical degree from Wits University in Johannesburg at age 23, Soon-Shiong moved to the U.S. to start surgical training at the University of California in Los Angeles. He joined the faculty of UCLA's medical school in 1983, focusing on diabetes treatment.

He left the university in 1991 to start VivoRX, a biotechnology firm. He renamed the company American Pharmaceutical Partners (APP) in 1997, and sold shares in a public offering four years later. He sold APP for $4.6 billion to Fresenius, a German drug manufacturer in 2008. He then sold Abraxis BioScience, which had been spun off from APP earlier, for $2.8 billion in cash and stock to Celgene in 2010.

The billionaire is married to Michele Chan, a former actress. The couple have two children and live in Los Angeles.

  • 1952 Born in Port Elizabeth, South Africa, to Chinese immigrants.
  • 1991 Leaves UCLA to start VivoRX, a biotechnology firm.
  • 1993 Performs first pig-to-man cell transplant for diabetic patients.
  • 2001 APP sells shares in an initial public offering.
  • 2008 Sells APP to drug manufacturer Fresenius for $4.6 billion in cash.
  • 2010 Celgene acquires his Abraxis Bioscience for $2.8 billion.
  • 2010 Buys 4.5 percent stake in L.A. Lakers from Earvin "Magic" Johnson.
  • 2012 Joins hedge fund manager Steven Cohen in failed bid for L.A. Dodgers.